Mark your calendar for the BIO International Convention, June 13-16, 2022, in San Diego, held by BioOhio national partner, BIO! More information about the 2022 event will be made available in the coming months. Sign up for notifications about this event at BIO.org.
Project Medtech and its Network of industry thought leaders have organized an interactive event to help founders build a successful medical technology company. The Symposium will include 1:1 time with subject matter experts, industry networking events, educational presentations, and thought leader panel discussions.
Grab your favorite drink (or just a drink), come learn and interact with industry experts while they discuss hot topics in Medtech. Speaker: Dr. Wessels founded LiquidSMARTS℠. He leads the global practice and is a member of the leadership team. He is passionate and dedicated to the improvement of human performance and ethical business practices in sales and marketing. His expertise comes from more than 25 years in the healthcare industry, including 14 years as a consultant to global and local marketing and sales teams. His clients gain rapid performance improvement through analysis, design, implementation of market approach, and commercial operations execution. He leads the field in providing micro-learning for business professionals. His micro-learning approach teaches people essential soft-skills and influencing and leadership behaviors in a few minutes per day.
Join BioOhio and AtriCure for a fun networking social in Mason, Ohio! This event will bring the region's life science community together for networking and connecting. Hear from our leaders, and enjoy food, beverages, and tours of AtriCure's headquarters. This event will also provide a wonderful opportunity to explore careers at this growing company! We look forward to seeing you there!
Join BioOhio and Project Medtech for a fun networking social in Cleveland, Ohio! This event will bring the region's life science community together for networking and connecting. We'll be at local gem and member Saucy Brew!
Join NAMSA and the U.S. Food and Drug Administration (FDA) as we present this upcoming webinar on July 20, 2022, regarding the Accreditation Scheme for Conformity Assessment (ASCA) Pilot Program, a first-of-its-kind conformity assessment program created by the U.S. FDA. During this webinar, the FDA will highlight how the ASCA Pilot Program streamlines aspects of conformity assessments for medical device submissions, as well as what manufacturers can expect when they submit ASCA test results to the government agency.
It’s time to refresh your network by seeing old friends and making new connections with other Pharma professionals at the PDA Midwest Ohio Networking Event on July 20th, at Home Bistro in Little Italy – Cleveland, OH. While networking, take advantage of the first-class service at Home Bistro, while indulging in some delicious food and signature cocktails. Pricing is free for this event; however, limited space is available. So, register now to confirm your ticket!
NAMSA and the Regulatory Affairs Professional Society (RAPS) will hold this webinar to bring awareness to the U.S. Food and Drug Administration’s (FDA) Quality System Regulation (QSR) proposed changes and what these may mean for the medical device industry and MedTech manufacturers as a whole.
In healthcare, we often hear the phrase “patient focus” which is designed to make decisions with the patient’s safety in mind. But all too often we forget that within the workplace, we also need to consider the safety and well-being of our sterile processing professionals who are facing the risks and doing the real work. This presentation will focus on the dangers and risks we face on a daily basis in our departments as well as provide solutions for those dangers and risks.
On this edition of Founder's Story, Rev 1 Ventures will host a breakfast with DASI Simulations's team who performs advanced individualized computational predictive modeling powered by artificial intelligence and computer vision to better plan for improved patient outcomes and reduced costs associated with Structural Heart Disease.